Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Okta
OKTA
$26.2B
| $20.2M | 0.01% |
234,531
-88,143
| -27% | -$6.71M |
|
577
Adtran
ADTN
$631M
| $20.2M | 0.01% |
1,275,937
+169,901
| +15% | +$2.95M |
|
578
Citizens Financial Group
CFG
$30.8B
| $20.1M | 0.01% |
663,046
-268,538
| -29% | -$10.5M |
|
579
First Busey Corp
BUSE
$2.57B
| $20M | 0.01% |
983,701
+76,001
| +8% | +$1.77M |
|
580
Nextpower Inc
NXT
$15.9B
| $19.9M | 0.01% |
+550,000
| New | +$17.4M |
|
581
CRA International
CRAI
$1.06B
| $19.9M | 0.01% |
184,573
+91,432
| +98% | +$10.8M |
|
582
Compass Therapeutics
CMPX
$409M
| $19.6M | 0.01% |
6,004,473
+65,183
| +1% | +$256K |
|
583
Anika Therapeutics
ANIK
$284M
| $19.6M | 0.01% |
682,124
+68,418
| +11% | +$2.04M |
|
584
Rhythm Pharmaceuticals
RYTM
$7.91B
| $19.6M | 0.01% |
1,097,573
-142,580
| -11% | -$3.58M |
|
585
Union Pacific
UNP
$174B
| $19.4M | 0.01% |
96,531
-871,680
| -90% | -$177M |
|
586
Gibraltar Industries
ROCK
$1.47B
| $19.3M | 0.01% |
398,499
+77,297
| +24% | +$3.95M |
|
587
Lowe's Companies
LOW
$124B
| $19.2M | 0.01% |
96,043
+17,272
| +22% | +$3.51M |
|
|
WBX
588
Wallbox
WBX
$80.3M
| $19.2M | 0.01% |
195,810
-30
| -0% | -$3K |
|
|
OLPX
589
DELISTED
Olaplex Holdings
OLPX
| $18.9M | 0.01% |
4,419,194
-770,016
| -15% | -$4.1M |
|
|
LOVE
590
LoveSac
LOVE
$257M
| $18.9M | 0.01% |
652,672
-970
| -0.1% | -$25.6K |
|
591
Southern Company
SO
$106B
| $18.7M | 0.01% |
269,445
+47,443
| +21% | +$3.19M |
|
592
Boeing
BA
$185B
| $18.5M | 0.01% |
87,337
+16,780
| +24% | +$3.49M |
|
593
CryoPort
CYRX
$753M
| $18.5M | 0.01% |
770,628
+137,682
| +22% | +$2.99M |
|
594
American Vanguard Corp
AVD
$61.2M
| $18.1M | 0.01% |
827,041
+6,758
| +0.8% | +$146K |
|
595
Cogent Biosciences
COGT
$6.65B
| $17.9M | 0.01% |
1,662,265
+60,068
| +4% | +$768K |
|
596
Alamos Gold
AGI
$13.9B
| $17.9M | 0.01% |
1,463,553
-178,370
| -11% | -$1.93M |
|
597
Atlanta Braves Holdings Series B
BATRK
$3.25B
| $17.9M | 0.01% |
529,959
+43,952
| +9% | +$1.48M |
|
598
Clear Secure
YOU
$4.96B
| $17.6M | 0.01% |
673,747
+4,822
| +0.7% | +$137K |
|
|
SAGE
599
DELISTED
Sage Therapeutics
SAGE
| $17.6M | 0.01% |
418,746
-200,544
| -32% | -$8.62M |
|
600
WaFd
WAFD
$2.8B
| $17.5M | 0.01% |
581,064
+568,478
| +4,517% | +$19.2M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.